http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
표승일 ( Seung Il Pyo ),이한주 ( Han Chu Lee ),서동대 ( Dong Dae Seo ),신정우 ( Jung Woo Shin ),류수형 ( Soo Hyung Ryu ),박영환 ( Young Hwan Park ),정영화 ( Young Hwa Chung ),이영상 ( Yung Sang Lee ),유은실 ( Eun Sil Yu ),서동진 ( 대한내과학회 2003 대한내과학회지 Vol.64 No.1
Background : Autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC), primary biliary cirrhosis (PBC), and autoimmune cholangiopathy (AIC) are major classes of liver diseases currently considered autoimmune. We investigated the clinical, biochemi
서동대(Dong Dae Seo),이윤정(Yun Jung Lee),박일권(Il Gwon Park),이현주(Hyun Ju Lee),박성제(Seong Je Park),표승일(Seung Il Pyo),윤길숙(Kil Sook Yun),서동완(Dong Wan Seo),이성구(Sung Koo Lee),김명환(Myung Hwan Kim),김기락(Ki Rhack Kim) 대한소화기학회 2001 대한소화기학회지 Vol.37 No.5
Endometriosis is defined as the presence of endometrial tissue outside the uterus. We experienced 51-year-old woman with symptom of epigastric pain and sign of a palpable mass on the left quadrant abdomen. A cystic mass in the tail area of the pancreas was found on CT scan and was removed surgically. It was a cystic mass originated from the mesentery and separated from the pancreas. It was diagnosed as endometrial cyst histopathologically. (Korean J Gastroenterol 2001;37:389-391)
급성 췌장염 환자에서 복강동맥 협착과 동반하여 발생한 비장경색의
김진건 ( Jin Gun Kim ),임동혁 ( Dong Hyuck Lim ),한봉준 ( Bong Jun Han ),표승일 ( Seung Il Pyo ),이숭환 ( Soong Hwan Lee ),김인숙 ( In Sook Kim ),전의용 ( Eui Yong Jeon ) 대한내과학회 2006 대한내과학회지 Vol.71 No.2
Prevalence of splenic infarction developed during acute pancreatitis is extremely rare. However, we recently experienced a case of 42-year-old woman who developed splenic infarction during acute alcoholic pancreatitis. There were sustained subjective symptoms and no resolution of image despite of conservative management, so we performed angiography to confirm whether vascular lesion existed or not. We found the significant celiac artery stenosis due to compression by median arcuate ligament and no visible thrombus. We report an unusual case of splenic infarction developed during acute recurrent pancreatitis possibly related with celiac artery stenosis.(Korean J Med 71:198-202, 2006)
Somatostatin Analogue(Octreotide)치료가 유효했던 췌장성 복수 1예
신정현,김명환,정성희,이성구,서동완,민영일,김선영,유교상,박은택,임병철,나비석,표승일 대한소화기학회 2000 대한소화기학회지 Vol.35 No.4
Pancreatic ascites has the characteristics of highly proteinaceous, amylase-rich intraperitoneal fluid. It usually occurs as a result of rupture of a pseudocyst or disruption of main pancreatic duct during the course of acute or chronic pancreatitis. It can be managed by traditional conservative methods including fasting, total parenteral nutrition and ascites tapping or surgical interventions. Recently, several cases of treating pancreatic ascites with somatostatin analogue (octreotide) successfully have been reported. We experienced a patient with chronic pancreatitis and pancreatic ascites, who was successfully treated by somatostatin analogue (octreotide).
각종 췌장질환에서 Somatostatin Analogue 사용 경험
김현영,김명환,박현주,이성구,서동완,민영일,신영록,이석수,전병민,표승일,유교상 대한소화기학회 2000 대한소화기학회지 Vol.35 No.6
Background/Aims: Octreotide, long-acting analogue of somatostatin, has been used for symptomatic carcinoid syndrome and vasoactive intestinal peptide-producing tumors. In pancreatic diseases, however, the effect of octreotide has not been settled yet. The aim of this study was to evaluate the effect of octreotide in various pancreatic diseases which did not respond to conventional medical treatment. Methods: We reviewed retrospectively the medical records of 28 patients who were admitted at the Asan Medical Center from January 1997 to June 1999. Their diseases were pancreatic fistula (n=9), pancreatic pseudocysts (n=17), and pancreatic ascites (n=2). Octreotide was administered subcutaneously at a dose of 0.1 mg every 12 hours. Results: In the cases of pancreatic fistulas, the mean output of baseline fistula was 289 cc/day. This was decreased to 178 cc/day on the first day of octreotide therapy and to 49 cc/day on the seventh day. Five (56%) patients eventually closed their fistulas. In the cases of pancreatic pseudocysts, 11 (65%) cases had showed complete resolution of pseudocysts. The remaining 6 cases which showed no improvement were treated operatively. In the cases of pancreatic ascites, the two patients (100%) were successfully treated with octreotide. Conclusions: Octreotide seems to be a safe and useful alternative therapy in patients with pancreatic fistulas, pseudocysts or ascites who do not respond to conventional medical management. Further detailed study may be necessary for the establishment of the role of octreotide in the treatment of various pancreatic diseases.